Wolff Wiese Magana LLC Moderna, Inc. Transaction History

Wolff Wiese Magana LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$85.37 - $115.44 $1,707 - $2,308	-20 Reduced 80.0%	5 $0
Q4 2023 Jan 16, 2024	SELL	$69.51 - $104.43 $834 - $1,253	-12 Reduced 32.43%	25 $2,000
Q3 2023 Oct 30, 2023	SELL	$96.41 - $126.61 $482 - $633	-5 Reduced 11.9%	37 $3,000
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $1,183 - $2,100	-10 Reduced 19.23%	42 $7,000
Q3 2022 Oct 26, 2022	BUY	$118.07 - $194.18 $1,180 - $1,941	10 Added 23.81%	52 $6,000
Q2 2022 Jul 15, 2022	SELL	$117.13 - $176.59 $468 - $706	-4 Reduced 8.7%	42 $6,000
Q4 2021 Jan 18, 2022	SELL	$225.82 - $368.51 $23,936 - $39,062	-106 Reduced 69.74%	46 $12,000
Q3 2021 Oct 15, 2021	BUY	$221.9 - $484.47 $16,864 - $36,819	76 Added 100.0%	152 $58,000
Q2 2021 Jul 15, 2021	BUY	$129.91 - $234.98 $1,169 - $2,114	9 Added 13.43%	76 $18,000
Q4 2020 Jan 27, 2021	BUY	$65.74 - $169.86 $4,404 - $11,380	67 New	67 $7,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

Stay updated on Wolff Wiese Magana LLC with notifications on news.